Evoke Pharma, Inc. (EVOK)

USD 3.09

(6.19%)

Gross Profit Summary of Evoke Pharma, Inc.

  • Evoke Pharma, Inc.'s latest annual gross profit in 2023 was 4.97 Million USD , up 132.84% from previous year.
  • Evoke Pharma, Inc.'s latest quarterly gross profit in 2024 Q2 was 2.5 Million USD , up 52.77% from previous quarter.
  • Evoke Pharma, Inc. reported a annual gross profit of 2.13 Million USD in annual gross profit 2022, up 65.76% from previous year.
  • Evoke Pharma, Inc. reported a annual gross profit of 1.28 Million USD in annual gross profit 2021, up 2125.31% from previous year.
  • Evoke Pharma, Inc. reported a quarterly gross profit of 1.64 Million USD for 2024 Q1, up 1.61% from previous quarter.
  • Evoke Pharma, Inc. reported a quarterly gross profit of 4.97 Million USD for 2023 FY, up 132.84% from previous quarter.

Annual Gross Profit Chart of Evoke Pharma, Inc. (2023 - 2011)

Historical Annual Gross Profit of Evoke Pharma, Inc. (2023 - 2011)

Year Gross Profit Gross Profit Growth
2023 4.97 Million USD 132.84%
2022 2.13 Million USD 65.76%
2021 1.28 Million USD 2125.31%
2020 -63.69 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Gross Profit Comparison of Evoke Pharma, Inc.

Name Gross Profit Gross Profit Difference
Esperion Therapeutics, Inc. 73.06 Million USD 93.186%
Theratechnologies Inc. 62.12 Million USD 91.986%
Safety Shot Inc -74.45 Thousand USD 6786.747%
Cosmos Health Inc. 4.34 Million USD -14.465%
Cronos Group Inc. 6.99 Million USD 28.782%
Ironwood Pharmaceuticals, Inc. 441.16 Million USD 98.871%
Kala Pharmaceuticals, Inc. -303 Thousand USD 1743.152%
Organogenesis Holdings Inc. 309.79 Million USD 98.393%
Universe Pharmaceuticals INC 10.07 Million USD 50.597%
ProPhase Labs, Inc. 16.23 Million USD 69.341%
Sonoma Pharmaceuticals, Inc. 4.74 Million USD -4.926%
Dynavax Technologies Corporation 182.11 Million USD 97.266%
Radius Health, Inc. 307.71 Million USD 98.382%
China SXT Pharmaceuticals, Inc. 553.97 Thousand USD -798.739%
Alvotech -69.42 Million USD 107.172%
Sunshine Biopharma, Inc. 8.33 Million USD 40.297%
Alpha Teknova, Inc. 10.29 Million USD 51.644%
Intra-Cellular Therapies, Inc. 430.62 Million USD 98.844%
SCYNEXIS, Inc. 124.51 Million USD 96.002%
Harrow Health, Inc. 90.55 Million USD 94.502%
Biofrontera Inc. 16.62 Million USD 70.056%
DURECT Corporation 6.83 Million USD 27.115%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 99.049%
ANI Pharmaceuticals, Inc. 305.3 Million USD 98.369%
OptiNose, Inc. 62.35 Million USD 92.015%
RedHill Biopharma Ltd. 3.05 Million USD -63.015%
Aquestive Therapeutics, Inc. 29.75 Million USD 83.266%
Cumberland Pharmaceuticals Inc. 33.48 Million USD 85.132%
SIGA Technologies, Inc. 122.09 Million USD 95.922%
Lifecore Biomedical, Inc. 41.85 Million USD 88.103%
Shineco, Inc. 882.16 Thousand USD -464.377%
Phibro Animal Health Corporation 312.48 Million USD 98.407%
Procaps Group S.A. 239.56 Million USD 97.922%
TherapeuticsMD, Inc. 1.3 Million USD -282.393%
Regencell Bioscience Holdings Limited -745.58 Thousand USD 767.762%
Viatris Inc. 6.43 Billion USD 99.923%
Sunshine Biopharma, Inc. 8.33 Million USD 40.297%
Rockwell Medical, Inc. 8.7 Million USD 42.799%
Incannex Healthcare Limited 12 Thousand USD -41389.592%
Aytu BioPharma, Inc. 54.58 Million USD 90.879%
Tilray Brands, Inc. 223.35 Million USD 97.771%
Collegium Pharmaceutical, Inc. 326.16 Million USD 98.474%
PetIQ, Inc. 252.74 Million USD 98.03%
Silver Spike Investment Corp. 8.1 Million USD 38.554%
Neurocrine Biosciences, Inc. 1.84 Billion USD 99.73%
Journey Medical Corporation 52.52 Million USD 90.52%
Alimera Sciences, Inc. 61.17 Million USD 91.861%
Petros Pharmaceuticals, Inc. 4.19 Million USD -18.791%
Assertio Holdings, Inc. 125.04 Million USD 96.019%
Shuttle Pharmaceuticals Holdings, Inc. -6811.00 USD 73198.679%
Embecta Corp. 749.9 Million USD 99.336%
Cyclo Therapeutics, Inc. -2.41 Million USD 306.572%
Procaps Group, S.A. 239.56 Million USD 97.922%
PainReform Ltd. -15 Thousand USD 33291.673%
Avadel Pharmaceuticals plc 27.11 Million USD 81.64%
Hempacco Co., Inc. -1.21 Million USD 509.493%
Talphera, Inc. -4.89 Million USD 201.711%
Pacira BioSciences, Inc. 490.3 Million USD 98.985%
Alvotech -69.42 Million USD 107.172%
Lantheus Holdings, Inc. 709.54 Million USD 99.298%
Kamada Ltd. 52.59 Million USD 90.533%
Indivior PLC 907 Million USD 99.451%
Currenc Group, Inc. 17.35 Million USD 71.314%
Flora Growth Corp. 17.73 Million USD 71.932%
Cyclo Therapeutics, Inc. -2.41 Million USD 306.572%
Evolus, Inc. 140.52 Million USD 96.457%
HUTCHMED (China) Limited 453.55 Million USD 98.902%
Amphastar Pharmaceuticals, Inc. 343.96 Million USD 98.553%
Akanda Corp. 111.44 Thousand USD -4367.291%